Hola Terreta, hola, Valencia! We hope you’re having an excellent start of the week!
"En el núcleo del DeepTech, florece la innovación que redefine nuestro mundo. Es el punto donde la ciencia se une con el coraje para enfrentar los mayores retos de la humanidad. Construyamos juntos el futuro, transformando posibilidades en realidades, un descubrimiento a la vez."
"At the heart of DeepTech, innovation thrives to redefine our world. It is where science meets courage to tackle humanity's greatest challenges. Together, let’s build the future, turning possibilities into realities, one discovery at a time."
The largest Startup and Deeptech companies newsletter in the world (+300 cities)
Sponsorship
This Newsletter is brought to you by DeepTech Builder
Turning science into world-changing companies. They speak both worlds—academic and corporate—and act as the bridge that takes breakthrough DeepTech to market.
Experimental drug speeds up myelin repair, restoring vision in mice
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.
AI-based pregnancy analysis discovers previously unknown warning signs for stillbirth and newborn complications
A new AI-based analysis of almost 10,000 pregnancies has discovered previously unidentified combinations of risk factors linked to serious negative pregnancy outcomes, including stillbirth.
Inside Ignite Next: the new scaleup program supercharging Europe’s deeptech
Europe’s newest deep-tech scaleup program aims to turn breakthrough science into industrial success through non-dilutive support, strategic partners, and a founder-first model.
B Capital leads $462M for Fervo’s Cape Station as geothermal eyes two-thirds of US data center demand
Texas-based geothermal frontrunner Fervo Energy has secured $462 million to accelerate construction of its first large-scale power plant and push forward new projects across the western U.S.
As bird protection becomes a wind-industry priority, Spoor secures €8 million to meet rising demand
Spoor, an Oslo-based startup that leverages AI to help wind farms monitor and protect wildlife, announced it has secured an €8 million Series A investment round to support further global expansion and new hires.
Gene therapy for severe epilepsy moves forward with EpilepsyGTx’s €28 million funding
EpilepsyGTx, a Cambridge-based BioTech startup focused on research and development of gene therapies to treat refractory epilepsy, today announced it has raised €28 million ($33 million) in Series A financing to advance its lead programme EPY201 through Phase 1/2a clinical trials.
